Pre- and postischemic effects of the NMDA receptor antagonist dizocilpine maleate (MK-801) on collateral cerebral blood flow

Journal of Neurosurgery

Volumn 87, Issue 6, 1997, Pages 927-933

  Robertson, Scott C ^b   Wetjen, Nicholas M ^b   Beer, Bradley J ^b   Loftus, Christopher M ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b NONE

Author keywords

Collateral cerebral blood flow; Dog; Glutamate antagonist; Microsphere; Stroke

Indexed keywords

DIZOCILPINE; DIZOCILPINE MALEATE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN ISCHEMIA; COLLATERAL CIRCULATION; CONTROLLED STUDY; DOG; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0030689052     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1997.87.6.0927     Document Type: Article

References (47)

1. Aoki M, Nomura F, Stromski ME, et al: Effects of MK-801 and NBQX on acute recovery of piglet cerebral metabolism after hypothermic circulatory arrest. J Cereb Blood Flow Metab 14:156-165, 1994
2. Baumbach GL, Heistad DD: Effects of sympathetic stimulation and changes in arterial pressure on segmental resistance of cerebral vessels in rabbits and cats. Circ Res 52:527-533, 1983
3. Buchan AM, Slivka A, Xue D: The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Res 574:171-177, 1992
4. Buckberg GD, Luck JC, Payne DB, et al: Some sources of error in measuring regional blood flow with radioactive microspheres. J Appl Physiol 31:598-604, 1971
5. Busija DW, Heistad DD, Marcus ML: Continuous measurement of cerebral blood flow in anesthetized cats and dogs. Am J Physiol 241:H228-H234, 1981
6. Choi DW: Cerebral hypoxia: some new approaches and unanswered questions. J Neurosci 10:2493-2501, 1990
7. Choi DW: Methods for antagonizing glutamate neurotoxicity. Cerebrovasc Brain Metab Rev 2:105-147, 1990
8. Coyle P, Heistad DD: Blood flow through cerebral collateral vessels in hypertensive and normotensive rats. Hypertension 8 (Suppl):II67-II71, 1986
9. Dawson VL, Dawson TM, London ED, et al: Nitric oxide mediates glutamate neurotoxicity in primary cortical culture. Proc Natl Acad Sci USA 88:6368-6371, 1991
10. Faraci FM, Breese KR: Dilatation of cerebral arterioles in response to N-methyl-D-aspartate: role of CGRP and acetylcholine. Brain Res 640:93-97, 1994
11. Faraci FM, Breese KR: Nitric oxide mediates vasodilatation in response to activation of N-methyl-D-aspartate receptors in brain. Circ Res 72:476-480, 1993
12. Faraci FM, Brian JE Jr: 7-Nitroindazole inhibits brain nitric oxide synthase and cerebral vasodilatation in response to N-Methyl-D-aspartate. Stroke 26:2172-2176, 1995
13. Faraci FM, Heistad DD: Regulation of large cerebral arteries and cerebral microvascular pressure. Circ Res 66:8-17, 1990
14. Garthwaite J, Charles SL, Chess-Williams R: Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336:385-388, 1988
15. Gilland E, Hagberg H: NMDA receptor-dependent increase of cerebral glucose utilization after hypoxia-ischemia in the immature rat. J Cereb Blood Flow Metab 16:1005-1013, 1996
16. Gillilan LA: Potential collateral circulation to the human cerebral cortex. Neurology 24:941-948, 1974
17. Ginsberg MD: Neuroprotection in brain ischemia: an update (Part 1). Neuroscientist 1:95-103, 1995
18. Greene GM, Muhonen MG, Detwiler KN, et al: Stem pressure at the origin of intracranial collateral vessels. Am J Physiol 262:H1294-H1297, 1992
19. Grotta J, Clark W, Coull B, et al: Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial. Stroke 26:602-605, 1995
20. Harrison DG, Chapman MP, Christy JP, et al: Studies of functional site of origin of native coronary collaterals. Am J Physiol 251:H1217-H1224, 1986
21. Harrison DG, Koyonagi S, Alden B, et al: Role of overlap perfusion in survival of non-infarcted risk zone following coronary occlusion. Fed Proc 40:602, 1981 (Abstract)
22. Heistad DD, Marcus ML, Sandberg S, et al: Effect of sympathetic nerve stimulation on cerebral blood flow and on large cerebral arteries of dogs. Circ Res 41:342-350, 1977
23. Heymann MA, Payne BD, Hoffman JIE, et al: Blood flow measurements with radionucleotide-labeled particles. Prog Cardiovasc Dis 20:55-79, 1977
24. Hirzel HO, Nelson GR, Sonnenblick EH, et al: Redistribution of collateral blood flow from necrotic to surviving myocardium following coronary occlusion in the dog. Circ Res 39:214-222, 1976
25. Hirzel HO, Sonnenblick EH, Kirk ES: Absence of a lateral border zone of intermediate creatine phosphokinase depletion surrounding a central infarct 24 hours after acute coronary occlusion in the dog. Circ Res 39:673-683, 1977
26. Ikonomidou C, Mosinger JL, Shadid Sales K, et al: Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-D-aspartate neurotoxicity. J Neurosci 9:2809-2818, 1989
27. Loftus CM, Greene GM, Detwiler KN, et al: Studies of collateral perfusion to canine middle cerebral artery territory. Am J Physiol 259:H560-H566, 1990
28. Marcus ML. The Coronary Circulation in Health and Disease. New York: McGraw-Hill, 1983, pp 224-228
29. Marcus ML, Heistad DD, Ehrhardt JC, et al: Total and regional cerebral blood flow measurement with 7-10-, 15-, 25-, and 50-μm microspheres. J Appl Physiol 40:501-507, 1976
30. McDonald JW, Silverstein FS, Johnston MV: MK-801 protects the neonatal brain from hypoxic-ischemic damage. Eur J Pharmacol 140:359-361, 1987
31. Mchedlishvili GI: Arterial Behavior and Blood Circulation in the Brain. New York: Consultants Bureau, 1986, pp 228-230
32. Muhonen MG, Greene GM, Heistad DD, et al: Mechanism of redistribution of cerebral blood flow during hypercarbia and seizures. Am J Physiol 266:H2074-H2081, 1994
33. Muhonen MG, Heistad DD, Faraci F, et al: Augmentation of blood flow through cerebral collaterals by inhibition of nitric oxide synthase. J Cereb Blood Flow Metab 14:704-714, 1994
34. Muhonen MG, Loftus CM, Heistad DD: Effects of adenosine and 2-chloroadenosine on cerebral collateral vessels. J Cereb Blood Flow Metab 15:1075-1081, 1995
35. Muhonen MG, Robertson SC, Gerdes JS, et al: Effects of serotonin on cerebral circulation following middle cerebral artery occlusion. J Neurosurg 87:301-306, 1997
36. Muhonen MG, Sawin PS, Loftus CM, et al. Pressure-flow relations in canine collateral-dependent cerebrum. Stroke 23: 988-994, 1992
37. Park CK, Nehls DG, Graham DI, et al: Focal cerebral ischemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia. J Cereb Blood Flow Metab 8: 757-762, 1988
38. Park CK, Nehls DG, Graham DI, et al: The glutamate antagonist MK-801 reduces focal ischaemic brain damage in the rat. Ann Neurol 24:543-551, 1988
39. Park CK, Nehls DG, Teasdale GM, et al: Effect of the NMDA antagonist MK-801 on local cerebral blood flow in focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 9: 617-622, 1989
40. Perkins WJ, Lanier WL, Karlsson BR, et al: The effect of the excitatory amino acid receptor antagonist dizocilipine maleate (MK-801) on hemispheric cerebral blood flow and metabolism in dogs: modification by prior complete cerebral ischemia. Brain Res 498:34-44, 1989
41. Robertson SC, Muhonen MG, Gerdes JS, et al: Effects of serotonin (5-HT) and selective 5-HT receptor antagonists on regional cerebral blood flow after middle cerebral artery occlusion. Surg Forum 47:561-563, 1996
42. Roussel S, Pinard E, Seylaz J: Effect of MK-801 on focal brain infarction in normotensive and hypertensive rats. Hypertension 19:40-46, 1992
43. Sharkey J, Ritchie IM, Butcher SP, et al: Differential effects of competitive (CGS19755) and non-competitive (MK 801) NMDA receptor antagonists upon local cerebral blood flow and local cerebral glucose utilisation in the rat. Brain Res 651: 27-36, 1994
44. Symon L: Haemodynamic studies of the leptomeningeal circulation in primates. Proc R Soc Med 61:610-612, 1968
45. Taylor GA, Trescher WH, Johnston MV, et al: Experimental neuronal injury in the newborn lamb: a comparison of N-methyl-D-aspartatic acid receptor blockade and nitric oxide synthesis inhibition on lesion size and cerebral hyperemia. Pediatric Res 38:644-651, 1995
46. Torregrosa G, Salom JB, Jover T, et al: Evidence of a direct constrictor action of MK-801 and its modulation by the endothelium in cerebral arteries. J Vasc Res 31:221-229, 1994
47. Yao H, Markgraf CG, Dietrich WD, et al: Glutamate antagonist MK-801 attenuates incomplete but not complete infarction in thrombotic distal middle cerebral artery occlusion in Wistar rats. Brain Res 642:117-122, 1994